Richmond Clinical Trials

The trials here

What the 11 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease4 trials
• Depression2 trials
• Asthma1 trial
• Heart failure1 trial
• Lupus (SLE)1 trial
• Obesity1 trial
• Type 2 diabetes1 trial

Phase

• Phase 25 trials
• Phase 35 trials
• Phase 1/21 trial

Status

• Active, not recruiting4 trials
• Recruiting4 trials
• Completed1 trial
• Not yet recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Eli Lilly and Company5 trials
• Hoffmann-La Roche3 trials
• Bristol-Myers Squibb1 trial
• Pfizer1 trial
• Zenas BioPharma (USA), LLC1 trial

Running trials

• Recruiting

  A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

  NCT07775300· Phase 3· Eli Lilly and Company· Source

  Contact: Harris Lari (principal investigator)

• Recruiting

  A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  NCT07412756· Phase 3· Eli Lilly and Company· Source

  Contact: Harris Lari (principal investigator)

• Recruiting

  A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

  NCT07219173· Phase 2· Eli Lilly and Company· Source

  Contact: Alexandra Lucas (principal investigator)

• Active, not recruiting

  A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

  NCT07169578· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

  NCT06976216· Phase 3· Bristol-Myers Squibb· Source

  Contact: Harris Lari, Site 0234

• Recruiting

  Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  NCT07177352· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

  NCT06991257· Phase 2· Pfizer· Source

• Active, not recruiting

  A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

  NCT06559163· Phase 2· Zenas BioPharma (USA), LLC· Source

• Active, not recruiting

  Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease

  NCT04639050· Phase 1/2· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting
• Depression2 recruiting
• Asthma1 recruiting

Closed trials

• Withdrawn

  A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes

  NCT06901349· Phase 2· Eli Lilly and Company· Source

• Completed

  Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy

  NCT06568042· Phase 2· Eli Lilly and Company· Source